Results 51 to 60 of about 155,038 (165)

Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia

Haematologica
Philadelphia-chromosome negative (Ph-neg) myeloproliferative neoplasms (MPNs) are hematopoietic stem disorders with a risk of progression to the accelerated-phase (AP) or blastphase (BP) that is influenced by clinical, pathologic, cytogenetic, and ...
Anand A. Patel, Raajit K. Rampal
doaj   +1 more source

Acute Leukemia and Pregnancy

European Journal of Inflammation, 2007
The combination of acute leukemia and pregnancy is infrequent. It is estimated to occur in less than 1 in 75,000 pregnancies. Maternal and fetal outcomes have improved substantially in recent years.
V. Karagiannis, A. Daniilidis, N. Klearhoy, A. Mamopoulos, V. Garipidou, S. Vakalopoulou, H. Zaboulis   +6 more
doaj   +1 more source

Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia

Leukemia & Lymphoma, 2013
We have analyzed the immunohistochemical expression of a wide range of molecules along with the proliferation rate separately in the proliferation centers (PCs) and in the rest of the tumor area, in lymph node or spleen sections of patients with chronic lymphocytic leukemia (CLL).
Sachanas, S., Levidou, G., Angelopoulou, M.K., Moschogiannis, M., Yiakoumis, X., Kalpadakis, C., Vassilakopoulos, T.P., Kontopidou, F., Tsirkinidis, P., Dimitrakopoulou, A., Kokoris, S., Dimitriadou, E., Kyrtsonis, M.-C., Panayiotidis, P., Papadaki, H., Patsouris, E., Korkolopoulou, P., Pangalis, G.A.   +17 more
openaire   +3 more sources

Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Journal of Hematology & Oncology, 2017
Background Acute myeloid leukaemia (AML) with 17p abnormalities (abn(17p)) carries a very poor prognosis due to high refractoriness to conventional chemotherapy, and allogeneic stem cell transplantation (allo-SCT) appears as the only potential curative ...
Xavier Poiré, Myriam Labopin, Johan Maertens, Ibrahim Yakoub-Agha, Didier Blaise, Norbert Ifrah, Gérard Socié, Tobias Gedde-Dhal, Nicolaas Schaap, Jan J. Cornelissen, Stéphane Vigouroux, Jaime Sanz, Lucienne Michaux, Jordi Esteve, Mohamad Mohty, Arnon Nagler   +15 more
doaj   +1 more source

Phase Angle as a Nutritional Assessment Method in Patients with Acute Myeloid Leukemia: A Cross-Sectional Study

Hematology
Abstract Background and Objectives: The phase angle, which is associated with cellular health, has garnered increasing attention as a noninvasive and objective method for nutritional assessment. However, the association between malnutrition and phase angle in patients with acute myeloid leukemia remains unreported.
Wei, Li, Jing, Zhang, Jing, Liu, Fang, Xu, Chao, Hua, Qiong, Qiu, Hua, Xie   +6 more
openaire   +2 more sources

Targeting survivin in leukemia

Oncology Reviews, 2011
Survivin, a member of the inhibitors of apoptosis family of proteins, is one of the most frequently upregulated transcripts in solid tumors and hematopoietic malignancies.
Bing Z. Carter, Michael Andreeff
doaj   +2 more sources

Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model

Journal of Hematology & Oncology
Patients with cytogenetically normal acute myeloid leukemia (CN-AML) may harbor prognostically relevant gene mutations and thus be categorized into one of the three 2022 European LeukemiaNet (ELN) genetic-risk groups.
Kellie J. Archer, Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Klaus H. Metzeler, Tobias Herold, Ann-Kathrin Eisfeld   +13 more
doaj   +1 more source

Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast]

Blood and Lymphatic Cancer: Targets and Therapy
Amer M Zeidan,1,* Courtney DiNardo2,* 1Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT, USA; 2Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA*These authors contributed equally to this ...
Zeidan AM, DiNardo C
doaj  

A multicenter cross-sectional study on factors associated with caregiving appraisal in pediatric acute leukemia caregivers

PLOS One
Introduction Caring for pediatric acute leukemia (PAL) patients poses significant psychological challenges for family caregivers, impacting their well-being and caregiving capacity. This multicenter study aimed to assess caregivers’ perception of their caregiving role using the revised Caregiving Appraisal Scale (rCAS) and identify factors associated ...
Phoebe Abonyo Ouru, Hong Zheng, Zhi Lin, Minghua Yang   +3 more
openaire   +3 more sources

Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation

Haematologica
Not available.
Gregory W. Roloff, Satyajit Kosuri, Mariam T. Nawas, Adam S. DuVall, Anand A. Patel, Peter A. Riedell, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Michael R. Bishop, Emma Nunley, Lucy A. Godley, Feighanne Hathaway, Daniela del Gaudio, Soma Das, Lorraine E. Canham, Michael W. Drazer   +16 more
doaj   +1 more source